| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3815606 | New Horizons in Translational Medicine | 2015 | 52 Pages |
Keywords
ABCcytotoxic T-lymphocyte antigenCTLAVEGFRHER-2PARPMBCHDACmTORPD-L1PD-1mAbTNBCCDKPI3KPFsMonoclonal antibodyAktprogression-free survivaloverall survivalCombination therapyEndocrine therapyMetastatic breast cancerBreast cancerTriple-negative breast cancerAdvanced breast cancerChemotherapyadverse eventVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)phosphatidylinositide 3-kinaseProgrammed death ligand-1Programmed death-1ResistanceAromatase inhibitorNab-paclitaxelmammalian target of rapamycinHormone therapyhistone deacetylaseProtein kinasecyclin-dependent kinasevascular endothelial growth factor receptorhormone receptorHuman epidermal growth factor receptor-2
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Sotirios G. Stergiopoulos,